(b) If the executive commissioner establishes a software under this subchapter, the commissioner shall publish a report not afterwards than January 1 of each odd-numbered 12 months within the medical effectiveness of the usage of tetrahydrocannabinols as well as their derivatives and almost every other health-related results on the study method.(d)